Anti-PEG10抗體[EPR8156(2)]-抗體-抗體-生物在線
深圳市宇德立生物科技有限公司
Anti-PEG10抗體[EPR8156(2)]

Anti-PEG10抗體[EPR8156(2)]

商家詢價

產品名稱: Anti-PEG10抗體[EPR8156(2)]

英文名稱: AA407948 antibody Edr antibody Embryonal carcinoma differentiation regulated antibody Embryonal carcinoma differentiation-regulated protein antibody

產品編號: ab181249

產品價格: null

產品產地: 英國

品牌商標: abcam

更新時間: null

使用范圍:

深圳市宇德立生物科技有限公司
  • 聯系人 :
  • 地址 : 深圳市寶安區西鄉寶民二路賢基大廈4E
  • 郵編 :
  • 所在區域 : 廣東
  • 電話 : 133****4454 點擊查看
  • 傳真 : 點擊查看
  • 郵箱 : 1484332550@qq.com

?

  • 特異性aAb181249 recognizes 2 isoforms of PEG10.
  • 經測試應用WB,?ICC/IFmore details
  • 種屬反應性
    與反應:?Mouse, Rat, Human
  • 免疫原

    Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human PEG10 aa 100-200. The exact sequence is proprietary.
    Database link:?Q86TG7

  • 陽性對照
    • JAR, 293, HeLa and HepG2 cell lysates; HepG2 cells.
  • 常規說明

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb??technology. RabMAb??technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

性能

應用

Our?Abpromise guarantee?covers the use of?ab181249?in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

應用 Abreviews 說明
WB ? 1/1000 - 1/10000. Detects a band of approximately 50, 100 kDa (predicted molecular weight: 80 kDa).
ICC/IF ? 1/100 - 1/250.

靶標

  • 功能Prevents apoptosis in hepatocellular carcinoma (HCC) cells through interaction with SIAH1, a mediator of apoptosis. May also have a role in cell growth promotion and hepatoma formation. Inhibits the TGF-beta signaling by interacting with the TGF-beta receptor ALK1. When overexpressed, induces the formation of cellular extension, such as filipodia in association with ALK1. Involved at the immediate early stage of adipocyte differentiation (By similarity). May bind to the 5'-GCCTGTCTTT-3' DNA sequence of the MB1 domain in the myelin basic protein (MBP) promoter.
  • 組織特異性Expressed in the cytotrophoblast layer but not in the overlying syncytiotrophoblast of the placenta. Expressed in prostate and breast carcinomas but not in normal breast and prostate epithelial cells. Expressed in the HepG2 cell line (at protein level). Expressed in brain, liver, spleen, kidney, thymus, lung, ovary, testis, reactive lymph node, skeletal muscle, adipose tissue and placenta. Expressed in pancreatic and hepatocellular carcinomas (HCC).
  • 序列相似性Contains 1 CCHC-type zinc finger.
  • 發展階段Expressed in placenta during the first trimester of gestation (at protein level). In placenta, down-regulated at early hypoxic phase, and highly activated at 11-12 week of gestation.
  • 翻譯后修飾Isoform RF1/RF2 undergoes proteolytic cleavage.
  • 細胞定位Nucleus. Cytoplasm. Detected predominantly in the cytoplasm of breast and prostate carcinomas, in hepatocellular carcinoma (HCC) and B-cell chronic lymphocytic leukemia (B-CLL) cells and in the HepG2 cell line. Colocalized with ALK1.
  • Anti-PEG10 antibody [EPR8156(2)] 圖像

    • Immunofluorescent analysis of HepG2 cells (paraformaldehyde-fixed, 4%)?labeling PEG10 with ab181249 at 1/250 dilution (red)?followed by Goat anti rabbit IgG (Alexa Fluor? 555) secondary at 1/200 dilution and counter-stained with DAPI (blue).

    • All lanes :?Anti-PEG10 antibody [EPR8156(2)] (ab181249) at 1/2000 dilution

      Lane 1 :?JAR cell lysate
      Lane 2 :?293 cell lysate
      Lane 3 :?HeLa cell lysate
      Lane 4 :?HepG2 cell lysate

      Lysates/proteins at 20 μg per lane.

      Secondary
      Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

      Predicted band size :?80 kDa